.Attributes Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective asks for incorporation of patients along with MASLD and also measurement of liver end results in cardio-- renal-- metabolic tests, when data advise mechanistically plausible benefits and also scientific safety-- and also summarizes factors to consider for trial concept as well as regulatory approval.